FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD
No abstract is available for this record.
Bibliographic context
- Journal
- Journal of Hepatology
- Date
- 2025-04-30
- Source
- OpenAlex
- PubMed
- Unavailable
Authors
Martina ColognesiDaniela GabbiaAnna SignorStefano ComaiAndrea MattareiGianfranco PasutLucia CentofantiStefano La RosaGiovanna FinziFranco FolliM. PappagalloPaolo L. ManfrediSara De Martin
Watch author
Topics and keywords
psilocybin PharmacologyReceptor Pharmacology Other PsilocybinSemaglutideSerotonergicAgonistMedicinePharmacologyPsychotherapistPsychologyInternal medicineHallucinogenEndocrinologySerotoninType 2 diabetesLiraglutideReceptorDiabetes mellitusNeurotransmitter Receptor Influence on BehaviorPsychedelics and Drug Studies
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
No close related records were found yet.